HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Morito Monden Selected Research

titanium silicide (TS-1)

3/2007[Combination therapy with bi-weekly docetaxel and 5'-deoxy-5-fluorouridine for advanced gastric cancer].
1/2006[A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer].
10/2005[A case of HCC with inferior caval vein tumor thrombus and multiple pulmonary metastases that remarkably responded to combination therapy of TS-1 and interferon-alpha].
10/2004[Two cases of advanced and recurrent gastric cancer treated with the combination of chemotherapy and radiation].
10/2004[Cases of postoperative hepatic metastasis from gastric cancer in which hepatic arterial infusion chemotherapy with 5-FU, adriamycin and cisplatin was performed after TS-1 chemotherapy].
4/2004[Weekly administration of paclitaxel as a second-line chemotherapy for advanced and recurrent gastric cancer].
12/2002[Three cases of advanced and recurrent gastric cancer treated with paclitaxel after TS-1 administration].
5/2002[Evaluation of the efficacy of TS-1 for peritoneal dissemination of gastric cancer using a newly-developed animal model].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Morito Monden Research Topics

Disease

129Neoplasms (Cancer)
03/2012 - 12/2000
66Hepatocellular Carcinoma (Hepatoma)
08/2018 - 01/2002
42Neoplasm Metastasis (Metastasis)
08/2018 - 01/2002
32Stomach Neoplasms (Stomach Cancer)
04/2010 - 12/2000
22Colorectal Neoplasms (Colorectal Cancer)
01/2016 - 06/2002
18Pancreatic Neoplasms (Pancreatic Cancer)
11/2016 - 01/2002
17Esophageal Neoplasms (Esophageal Cancer)
11/2010 - 01/2002
17Thrombosis (Thrombus)
05/2009 - 05/2003
17Carcinoma (Carcinomatosis)
03/2008 - 01/2002
12Lymphatic Metastasis
11/2008 - 12/2000
10Adenocarcinoma
01/2008 - 12/2000
9Breast Neoplasms (Breast Cancer)
11/2004 - 07/2002
8Colonic Neoplasms (Colon Cancer)
12/2008 - 01/2002
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2008 - 07/2002
7Neoplasm Micrometastasis
01/2016 - 07/2002
6Liver Cirrhosis (Hepatic Cirrhosis)
11/2007 - 08/2003
5Cholangiocarcinoma
11/2008 - 04/2002
5Esophageal Squamous Cell Carcinoma
11/2008 - 10/2004
4Fibrosis (Cirrhosis)
01/2007 - 08/2003
4Rectal Neoplasms (Rectal Cancer)
11/2006 - 10/2003
4Carcinogenesis
05/2006 - 11/2002
3Infections
10/2010 - 01/2006
3Hepatitis C
12/2009 - 01/2006
3Adenoma (Adenomas)
02/2008 - 11/2002
3End Stage Liver Disease
11/2007 - 12/2005
3Liver Diseases (Liver Disease)
04/2007 - 10/2003

Drug/Important Bio-Agent (IBA)

36Fluorouracil (Carac)FDA LinkGeneric
02/2012 - 01/2002
26Proteins (Proteins, Gene)FDA Link
11/2008 - 06/2002
23Interferon-alpha (Interferon Alfa)IBA
11/2008 - 01/2002
16Messenger RNA (mRNA)IBA
01/2016 - 01/2002
15InterferonsIBA
08/2018 - 11/2002
10GemcitabineFDA Link
05/2011 - 02/2003
10Cisplatin (Platino)FDA LinkGeneric
11/2010 - 09/2002
10Doxorubicin (Adriamycin)FDA LinkGeneric
03/2008 - 11/2002
9Biological ProductsIBA
11/2010 - 04/2002
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2008 - 02/2004
8titanium silicide (TS-1)IBA
03/2007 - 05/2002
7Tumor Biomarkers (Tumor Markers)IBA
05/2011 - 01/2002
7Pharmaceutical PreparationsIBA
12/2009 - 07/2002
7Valosin Containing ProteinIBA
08/2004 - 02/2003
6Carcinoembryonic AntigenIBA
01/2016 - 06/2002
6DNA (Deoxyribonucleic Acid)IBA
04/2008 - 01/2003
6Irinotecan (Camptosar)FDA LinkGeneric
02/2008 - 10/2004
6Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2007 - 10/2005
6Indicators and Reagents (Reagents)IBA
04/2007 - 09/2002
6Paclitaxel (Taxol)FDA LinkGeneric
01/2007 - 12/2002
6NF-kappa B (NF-kB)IBA
08/2004 - 02/2003
5Biomarkers (Surrogate Marker)IBA
11/2016 - 12/2006
5XenonIBA
03/2012 - 08/2003
5OligonucleotidesIBA
11/2010 - 05/2003
5AntigensIBA
11/2008 - 02/2003
4RNA (Ribonucleic Acid)IBA
01/2016 - 02/2004
4UracilIBA
05/2011 - 01/2006
4TegafurIBA
05/2011 - 01/2006
4AngiopoietinsIBA
04/2008 - 02/2004
4Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2008 - 08/2005
4hepatoma-derived growth factorIBA
07/2007 - 01/2006
4Cadherins (E-Cadherin)IBA
06/2007 - 12/2000
4Taxoids (Taxanes)IBA
03/2007 - 09/2002
4Cyclin D1IBA
08/2006 - 04/2002
4TubulinIBA
02/2006 - 09/2002
4LigandsIBA
12/2004 - 08/2003
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
08/2004 - 06/2002
4Codon (Codons)IBA
10/2003 - 09/2002
3SteroidsIBA
11/2009 - 08/2004
3BilirubinIBA
01/2009 - 11/2007
3Matrix Metalloproteinases (MMPs)IBA
12/2008 - 01/2007
3Complementary DNA (cDNA)IBA
12/2008 - 01/2007
3SurvivinIBA
09/2008 - 08/2005
3Interferon-betaIBA
12/2007 - 12/2003
3Proliferating Cell Nuclear Antigen (PCNA)IBA
10/2007 - 09/2002
3Antineoplastic Agents (Antineoplastics)IBA
09/2007 - 01/2003
3Thymidylate SynthaseIBA
07/2007 - 05/2003
3Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
07/2007 - 10/2004
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
07/2007 - 01/2005
3poliovirus receptorIBA
06/2007 - 10/2005
3Amino AcidsFDA Link
05/2007 - 08/2003
3CholesterolIBA
05/2007 - 07/2002
3Keratins (Keratin)IBA
05/2007 - 10/2002
3Docetaxel (Taxotere)FDA Link
03/2007 - 08/2003
3Hormones (Hormone)IBA
02/2007 - 03/2004
3Estrogen ReceptorsIBA
01/2007 - 04/2003
3Leucovorin (Folinic Acid)FDA Link
11/2006 - 09/2002

Therapy/Procedure

66Therapeutics
08/2018 - 01/2002
46Drug Therapy (Chemotherapy)
11/2010 - 09/2002
15Liver Transplantation
12/2009 - 03/2002
10Combination Drug Therapy (Combination Chemotherapy)
11/2009 - 01/2004
8Neoadjuvant Therapy
11/2010 - 09/2002
8Chemoradiotherapy
11/2009 - 10/2003
8Lymph Node Excision (Lymph Node Dissection)
01/2008 - 07/2002
7Radiotherapy
11/2010 - 09/2004
7Hepatectomy
04/2008 - 01/2002
5Gastrectomy
02/2007 - 01/2003
4Splenectomy
05/2009 - 02/2005
4Combined Modality Therapy
11/2008 - 10/2003
3Pancreaticoduodenectomy
11/2009 - 01/2002
3Adjuvant Chemotherapy
11/2008 - 03/2004
3Thrombectomy
11/2008 - 04/2007
3Esophagectomy
09/2007 - 03/2005
3Oral Administration
11/2006 - 01/2003